Home > Healthcare > Biotechnology > Biopharma > Polyclonal Antibodies Market
Polyclonal Antibodies Market Size
- Report ID: GMI7456
- Published Date: Nov 2023
- Report Format: PDF
Polyclonal Antibodies Market Size
Polyclonal Antibodies Market size was valued more than USD 1.5 Billion in 2022 and is projected to grow at a CAGR of over 5.9% between 2023 and 2032. The rising incidence of chronic diseases such as cancer, autoimmune conditions, and infectious diseases anticipates propelling the industry demand. For instance, there were around 20 million new cancer cases, and the cancer burden is projected to rise by about 60% in the next two decades, reaching approximately 30 million new cases by 2040. This surge in cancer cases is expected to drive the demand for diagnostics and therapeutics.
Polyclonal antibodies are a group of antibodies that are produced by different B cells in the immune system. These antibodies are diverse and can recognize and bind to various epitopes (specific regions on an antigen) due to their origins from multiple B cell clones. Due to their broad epitope recognition, polyclonal antibodies are valuable tools in various applications, including diagnostics, therapeutics, and research.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Polyclonal Antibodies Market Size in 2022: | USD 1.5 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5.9% |
| 2032 Value Projection: | USD 2.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 322 |
| Segments covered: | Product, Application, Route of Administration, Source, End-user, & Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Polyclonal Antibodies Market Scope
